These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29023666)

  • 1. Nutritional intervention and neurodevelopmental outcome in infants with suspected cerebral palsy: the Dolphin infant double-blind randomized controlled trial.
    Andrew MJ; Parr JR; Montague-Johnson C; Laler K; Qi C; Baker B; Sullivan PB
    Dev Med Child Neurol; 2018 Sep; 60(9):906-913. PubMed ID: 29023666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial.
    Andrew MJ; Parr JR; Montague-Johnson C; Laler K; Holmes J; Baker B; Sullivan PB
    Dev Med Child Neurol; 2018 Sep; 60(9):897-905. PubMed ID: 29806081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment, and children with suspected or confirmed cerebral palsy.
    Andrew MJ; Parr JR; Montague-Johnson C; Braddick O; Laler K; Williams N; Baker B; Sullivan PB
    BMC Pediatr; 2015 Mar; 15():22. PubMed ID: 25885548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dolphin CONTINUE: a multi-center randomized controlled trial to assess the effect of a nutritional intervention on brain development and long-term outcome in infants born before 30 weeks of gestation.
    Janson E; Koolschijn PCMP; Schipper L; Boerma TD; Wijnen FNK; de Boode WP; van den Akker CHP; Licht-van der Stap RG; Nuytemans DHGM; Onland W; Obermann-Borst SA; Dudink J; de Theije CGM; Benders MJNL; van der Aa NE
    BMC Pediatr; 2024 Jun; 24(1):384. PubMed ID: 38849784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
    Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
    JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
    Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
    BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and Neurodevelopmental Outcomes of Preterms Resuscitated With Different Oxygen Fractions.
    Boronat N; Aguar M; Rook D; Iriondo M; Brugada M; Cernada M; Nuñez A; Izquierdo M; Cubells E; Martinez M; Parra A; van Goudoever H; Vento M
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
    Makrides M; Gibson RA; McPhee AJ; Yelland L; Quinlivan J; Ryan P;
    JAMA; 2010 Oct; 304(15):1675-83. PubMed ID: 20959577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting neurodevelopmental outcome at 2 years in very preterm infants below 1250 grams: a prospective study.
    Agarwal PK; Shi L; Rajadurai VS; Zheng Q; Yang PH; Khoo PC; Quek BH; Daniel LM
    J Perinatol; 2018 Aug; 38(8):1093-1100. PubMed ID: 29855557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
    Juul SE; Comstock BA; Wadhawan R; Mayock DE; Courtney SE; Robinson T; Ahmad KA; Bendel-Stenzel E; Baserga M; LaGamma EF; Downey LC; Rao R; Fahim N; Lampland A; Frantz ID; Khan JY; Weiss M; Gilmore MM; Ohls RK; Srinivasan N; Perez JE; McKay V; Vu PT; Lowe J; Kuban K; O'Shea TM; Hartman AL; Heagerty PJ;
    N Engl J Med; 2020 Jan; 382(3):233-243. PubMed ID: 31940698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children.
    Guillot M; Synnes A; Pronovost E; Qureshi M; Daboval T; Caouette G; Olivier F; Bartholomew J; Mohamed I; Massé E; Afifi J; Hendson L; Lemyre B; Luu TM; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Ducruet T; Ndiaye ABKT; Angoa G; Sériès T; Piedboeuf B; Nuyt AM; Fraser W; Mâsse B; Lacaze-Masmonteil T; Lavoie PM; Marc I
    Pediatrics; 2022 Jul; 150(1):. PubMed ID: 35652296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Neurodevelopmental Outcomes Associated with Bovine Milk Fat Globule Membrane and Lactoferrin in Infant Formula: A Randomized, Controlled Trial.
    Li F; Wu SS; Berseth CL; Harris CL; Richards JD; Wampler JL; Zhuang W; Cleghorn G; Rudolph CD; Liu B; Shaddy DJ; Colombo J
    J Pediatr; 2019 Dec; 215():24-31.e8. PubMed ID: 31668885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayley-III scales at 12 months of corrected age in preterm infants: Patterns of developmental performance and correlations to environmental and biological influences.
    Velikos K; Soubasi V; Michalettou I; Sarafidis K; Nakas C; Papadopoulou V; Zafeiriou D; Drossou V
    Res Dev Disabil; 2015; 45-46():110-9. PubMed ID: 26232203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: a randomised controlled trial.
    Meldrum SJ; D'Vaz N; Simmer K; Dunstan JA; Hird K; Prescott SL
    Br J Nutr; 2012 Oct; 108(8):1443-54. PubMed ID: 22348468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prenatal docosahexaenoic acid supplementation on infant outcomes in African American women living in low-income environments: A randomized, controlled trial.
    Keenan K; Hipwell A; McAloon R; Hoffmann A; Mohanty A; Magee K
    Psychoneuroendocrinology; 2016 Sep; 71():170-5. PubMed ID: 27290652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.
    Makrides M; Gibson RA; McPhee AJ; Collins CT; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Smithers LG; Willson K; Ryan P
    JAMA; 2009 Jan; 301(2):175-82. PubMed ID: 19141765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial.
    Devlin AM; Chau CMY; Dyer R; Matheson J; McCarthy D; Yurko-Mauro K; Innis SM; Grunau RE
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.